Triple-negative breast cancer trials recruiting in Louisiana

All Triple-negative breast cancer trials nationally

Cities in Louisiana

Recruiting trials in Louisiana

• A Phase 0 Multicenter Study of the Pharmacodynamic Effects of Intratumoral Microdose Administration of PBA-0111 in Patients With Solid Tumors
  NCT06700070 · Phase: Early Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · Louisiana: Shreveport
• Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)
  NCT06393374 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · Louisiana: Alexandria, Monroe, Shreveport
• Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Negative Breast Cancer Who Have Residual Invasive Disease After Surgery and Neoadjuvant Therapy (ASCENT-05/AFT-65 OptimICE-RD/GBG 119/NSABP B-63)
  NCT05633654 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · Louisiana: Baton Rouge, New Orleans